NCT06341283View on ClinicalTrials.gov

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

July 1, 2025

Conditions
Breast CancerNeoplasmsBreast Diseases
Interventions
DRUG

Abemaciclib and Letrozole/Anastrozole

Take the treatment with Abemaciclib and Letrozole/Anastrozole at the same time.

DRUG

Letrozole or Anastrozole

Take the treatment with Letrozole or Anastrozole.

DRUG

Abemaciclib and Fulvestrant

Take the treatment with Abemaciclib and Fulvestrant at the same time.

DRUG

Fulvestrant

Take the treatment with Fulvestrant only.

Trial Locations (1)

Unknown

Clinical Research Center, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT06341283 - A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer | Biotech Hunter | Biotech Hunter